Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Gordona
    Junior Member
    • Sep 2010
    • 7

    #1

    Combining >two mappings (reference and de novo) in hexaploid wheat

    Hi there,
    Has anyone combined more than one mapping data set when analysing with DESeq2 or EdgeR?

    We are looking at the interaction of a fungus and hexaploid wheat as an infection takes place and have sequenced using Illumina 100bp SE reads.

    We have the genome sequenced of the fungus and have used the predicted coding sequences as a "reference genome" to map to, and have used the NCBI Unigene set (of 168 000 genes) for the wheat "reference genome".
    We have just done a de novo assembly of the leftover unmapped reads and have a new set of contigs that we've used as a third "reference genome" and now have mapped count data for that.

    Are there major issues with combining these datasets and running DE analysis in one go?

    When the de novo contigs (729000) are blasted against the NCBI wheat unigene set, 321000 align, suggesting that we've generated contigs for the two other homeologues. Has anyone else used the Wheat Unigene set and found the same? How have you analysed homeologous gene expression?

    Any advice welcome,
    Many thanks,

    Anna

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...